# When a sore joint is worth getting checked *When to get checked | Joint Regeneration Gilbert* > Joint regeneration Gilbert answers about lasting soreness, urgent warning signs, exam details, and care choices near Gilbert. ## When is it worth having this joint checked? Arrange an exam once the ache comes back often or limits ordinary parts of your day. You don't need to wait until walking, sleeping, or dressing becomes very hard. The doctor checks swelling, lost motion, weakness, and effects left by an old injury. That exam can separate joint wear from tendon strain or pain coming from elsewhere. ## What to tell the doctor Point to the sore area and call it sharp, dull, burning, or stiff. Give the starting date, then name the movements that hurt and the things that help. Mention falls, past injuries, fever, swelling, numbness, or weakness. Those details matter because the joint isn't always the only source. Bring a medicine list, therapy notes, and old X-rays when available. Name one task you want back, such as using stairs or sleeping well. ## When to seek quick medical help A badly swollen joint that feels hot, along with fever, can signal infection. Get prompt medical care, especially when you also feel ill. After a fall, get quick help when standing on that side isn't possible. A joint that looks misshapen, locks, or swells quickly also needs an early exam. New weakness in a leg with lost bladder control can point to nerve trouble. Go to urgent care or an emergency room now, since the cause may be outside the joint. Fast-worsening soreness with night pain or weight loss also needs medical review. Don't wait for a routine clinic visit when these warning signs appear. ## What to do if routine care hasn't helped Review the cause before adding care, because joints can change over time. Ask whether today's exam still matches the old X-ray and your current soreness. If routine care hasn't helped, QC Kinetix offers consultations in Chandler about regenerative treatments, meaning non-surgical shots prepared from blood or marrow, the soft center inside bone. A doctor reviews your joint and health before discussing a possible shot. Results aren't certain, and these choices don't promise new cartilage. Ask what relief may feel like, when to judge it, and which costs are yours. The exam may point toward different care instead. You can consider that choice before agreeing to a shot. ## Sources 1. A GRADE-rated systematic review and meta-analysis of 16 randomized trials (807 participants) found that MSC therapy for chronic knee OA pain PROBABLY RESULTS IN LITTLE TO NO DIFFERENCE in pain relief at 3-6 months (WMD -0.74 cm on a 10 cm VAS against a minimally important difference of 1.5 cm) or physical functioning (WMD 2.23 on the SF-36 100-point subscale against a 10-point MID), both moderate certainty; at 12 months pain was again probably little-to-no-different (WMD -0.73 cm). The measured effect is real but sits BELOW the threshold at which a patient would notice it. Sadeghirad B, et al. — [Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials.](https://pubmed.ncbi.nlm.nih.gov/38777213/). *Osteoarthritis and cartilage*, 2024. DOI: 10.1016/j.joca.2024.04.021. 2. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit. Awad G, et al. — [Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/41863718/). *Clinical rheumatology*, 2026. DOI: 10.1007/s10067-026-08042-w. 3. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 4. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred. Mautner K, et al. — [Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.](https://pubmed.ncbi.nlm.nih.gov/37919438/). *Nature medicine*, 2023. DOI: 10.1038/s41591-023-02632-w. 5. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products. US Food and Drug Administration, Center for Biologics Evaluation and Research — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA*, 2020. 6. The strongest recent POSITIVE signal: a meta-analysis of 10 RCTs (818 patients, KL I-III) found intra-articular MSC injection beat hyaluronic acid at 12 months on WOMAC total (MD -10.22), VAS (MD -1.31) and on the MRI Whole-Organ Magnetic Resonance Imaging Score (MD -26.01), all reaching the minimal clinically important difference, with no significant difference in adverse events. Recorded here at full weight: this result and the negative RESTORE and Mautner trials are both in the literature, and an honest page reports both. Jin WS, et al. — [Mesenchymal Stem Cells Injection Is More Effective Than Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis With Similar Safety: A Systematic Review and Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/39154667/). *Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association*, 2025. DOI: 10.1016/j.arthro.2024.07.027. 7. The evidence overview underpinning the 2020 EULAR recommendations on intra-articular therapies pooled 29 quality-appraised systematic reviews. Hyaluronic acid showed a small effect on pain and function in KNEE OA but not in hip OA or shoulder capsulitis; intra-articular glucocorticoid showed small effects in knee OA and on function in hip OA and shoulder capsulitis; PRP showed benefit in knee OA but NOT in hip OA, and mesenchymal stem cells behaved similarly. Overall conclusion: most intra-articular therapies exert SMALL effects and are well tolerated. Rodriguez-García SC, et al. — [Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: an overview of systematic reviews.](https://pubmed.ncbi.nlm.nih.gov/34103406/). *RMD open*, 2021. DOI: 10.1136/rmdopen-2021-001658. ## What to do when soreness stays When soreness stays, QC Kinetix offers consultations in Chandler about regenerative treatments, meaning non-surgical shots prepared from blood or marrow, the soft center inside bone. A doctor examines your joint before discussing the choices. Bring old X-rays and soreness notes, plus a current list of medicines. Call (602) 837-PAIN when you're ready to ask about an appointment. Ask what the shot contains, what it costs, and what relief is reasonable. You don't need to decide before those questions are answered. Book an appointment: --- Clear help for a sore joint. Joint regeneration Gilbert answers for aching joints: why they hurt, easy changes, urgent symptoms, and local care. Clear answers for aching joints, home steps, urgent symptoms, and local care in Gilbert. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Chandler location named here, and the business benefits when readers book through its links. © 2026 Gilbert Joint Evidence Studio. General education, not medical advice for an individual joint; seek care promptly for urgent symptoms.